SECsense Logo

Vertex Pharmaceuticals Inc. 8-K Report: Key Updates from May 19, 2025

$VRTX
Form 8-K
Filed on: 2025-05-19
Source
Vertex Pharmaceuticals Inc. 8-K Report: Key Updates from May 19, 2025

The extracted key information from the provided section of the financial report is as follows:

  1. Entity Information:
  • Company Name: Vertex Pharmaceuticals Inc.
  • Location: 50 Northern Avenue, Boston, MA, 02210
  • Contact Number: 617-341-6100
  • CIK (Central Index Key): 0000875320
  1. SEC Filing Details:
  • Filing Type: 8-K (a report of unscheduled material events or corporate changes)
  • Filing Date: May 19, 2025
  • Securities Registration Number: 000-19319
  • Tax ID Number: 04-3039129
  1. Stock Information:
  • Common Stock Par Value: $0.01
  • Ticker Symbol: VRTX
  • Exchange: NASDAQ
  1. Report Context:
  • Period Start and End Date: Both dated May 19, 2025, indicating a single-day event or report.

Insights:

  • The filing is an 8-K, suggesting that Vertex Pharmaceuticals may be reporting a significant event that could impact investors or stakeholders.
  • The date indicates that the report is relevant to a specific event that occurred on May 19, 2025.
  • The common stock's par value and ticker information may be relevant for investors looking to assess the company's market position and stock performance.

This section indicates an ongoing operational and reporting activity by Vertex Pharmaceuticals, which is pertinent for stakeholders monitoring the company's developments.